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Despite intensive studies on sheep scrapie, a number of questions remain unanswered, such as
the natural mode of transmission and the amount of infectivity which accumulates in edible tissues
at different stages of scrapie infection. Studies using the mouse model proved to be useful for
recognizing scrapie strain diversity, but the low sensitivity of mice to some natural scrapie isolates
hampered further investigations. To investigate the sensitivity of bank voles (Myodes glareolus) to
scrapie, we performed end-point titrations from two unrelated scrapie sources. Similar titres
[105.5 ID50 U g
”1 and 105.8 ID50 U g
”1, both intracerebrally (i.c.)] were obtained, showing that
voles can detect infectivity up to 3–4 orders of magnitude lower when compared with laboratory
mice. We further investigated the relationships between PrPSc molecular characteristics, strain
and prion titre in the brain and tonsil of the same scrapie-affected sheep. We found that protease-
resistant PrPSc fragments (PrPres) from brain and tonsil had different molecular features, but
induced identical disease phenotypes in voles. The infectivity titre of the tonsil estimated by
incubation time assay was 104.8 i.c. ID50 U g
”1, i.e. fivefold less than the brain. This compared well
with the relative PrPres content, which was 8.8-fold less in tonsil than in brain. Our results suggest
that brain and tonsil harboured the same prion strain showing different glycoprofiles in
relation to the different cellular/tissue types in which it replicated, and that a PrPSc-based estimate
of scrapie infectivity in sheep tissues could be achieved by combining sensitive PrPres detection
methods and bioassay in voles.
INTRODUCTION
Scrapie of sheep and goat is a transmissible spongiform
encephalopathy (TSE) or prion disease. The key feature of
this group of fatal neurodegenerative diseases is represented
by the post-translational modification of the cellular prion
protein, PrPC, into an abnormal protease-resistant isoform
named PrPSc. In TSEs, the accumulation of PrPSc in tissues
of infected individuals usually correlates with the presence of
infectivity (McKinley et al., 1983; Race et al., 2001).
Although no evidence exists that scrapie transmits to
humans, sheep tissues containing the highest levels of
infectivity are excluded from human consumption, as a
precautionary measure. The Regulation (EC) 999/2001
(European Parliament, 2001) includes the spleen and ileum
of sheep and goats of all ages as specified risk material
(SRM), whilst the skull, including brain, eyes, tonsils and
spinal cord are also considered SRM in animals over
12 months. This approach is based on available knowledge,
but there is an increasing need to refine and optimize it by
updating information on infectivity in other tissues such as
skeletal muscle and viscera.
Natural sheep scrapie represents the prototype of TSEs and
an appropriate model for acquiring knowledge on the
infectivity of tissues. The occurrence of natural and
experimental scrapie has been linked to polymorphisms
Published online ahead of print on 30 September 2008 as DOI
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at codons 136 (A/V), 154 (R/H) and 171 (Q/R) of the PrP
gene (Belt et al., 1995). Sheep carrying the V136/R154/
Q171 (or VRQ) allele are considered the most susceptible
to scrapie, while the ARR allele confers resistance. In sheep
breeds, like Suffolk and Sarda sheep, which lack the VRQ
allele, the ARQ/ARQ genotype is considered the most
susceptible to scrapie (Agrimi et al., 2003; Baylis &
Goldmann, 2004).
Early research on tissue distribution of infectivity in sheep
affected by scrapie relied on bioassays in small ruminants
or mice (reviewed by Detwiler & Baylis, 2003). These
studies suggested an early replication of the agent in the
lymphoreticular and peripheral nervous tissues before
entering the brain, and provided the basis for the
categorization of sheep tissues in relation to the levels of
infectivity (World Health Organization, 2006). However, it
should be noted that these animal models present some
critical limitations. Bioassays in sheep are hampered by the
impractical use of large animals. On the other hand, data
produced by the use of the mouse model also has serious
limitations, considering the inefficient or even unsuccessful
transmission sometimes observed following experimental
inoculation of natural scrapie (Bruce et al., 2002). The
transmission of scrapie isolates from ARQ/ARQ sheep to
wild-type mice has been reported to be difficult (Bruce
et al., 2002; Piening et al., 2006). This also suggests that the
actual distribution and quantification of infectivity in
tissues of scrapie-affected sheep could be underestimated
or biased by the different susceptibility of animal models to
the various scrapie strains.
After the discovery of PrPSc as a marker of infection
(Bendheim et al., 1984), rapid methods for detecting
scrapie infection by Western-blot and ELISA became
available. Recent studies conducted by these means reveal
a widespread distribution of PrPSc, including skeletal
muscles (Andre´oletti et al., 2004), tongue (Casalone et al.,
2005), placenta (Race et al., 1998), kidneys (Siso´ et al.,
2006; Ligios et al., 2007), salivary glands (Vascellari et al.,
2007) and skin (Thomzig et al., 2007). Although PrPSc is
believed to be the most useful marker of TSEs, the
relationship between the amount of PrPSc and the level of
infectivity of a given tissue is not known, making it difficult
for policy makers to derive meaningful information from
studies relying solely on PrPSc detection. Bioassays remain
the only effective tools for detecting and quantifying TSE
agents. Furthermore, the recent discovery of infectivity in
biological fluids in which PrPSc has never been reported,
such as the blood of scrapie-affected sheep (Hunter et al.,
2002) and the saliva of elk with chronic wasting disease
(CWD) (Mathiason et al., 2006), emphasizes the need for
more sensitive and rapid bioassays for scrapie.
Recent studies on transgenic mice overexpressing PrP
homologous to the donor species have demonstrated that
such expression can abrogate the species barrier (Scott
et al., 1989). These transgenic mouse models offer
improved bioassay sensitivity for human, bovine and
cervid TSE infections (Safar et al., 2002, 2005;
Buschmann & Groschup, 2005; Angers et al., 2006).
With the aim of improving bioassay sensitivity for sheep
scrapie, transgenic mice overexpressing either the ARQ or
the VRQ ovine prion protein alleles have recently been
generated (Crozet et al., 2001; Vilotte et al., 2001; Cordier
et al., 2006). These mouse models were shown to abrogate
the species barrier when challenged with scrapie, and
allowed the transmission of scrapie isolates with different
PrP genotypes, irrespective of the homology with the
transgene used in the mouse, in that both ARQ and VRQ
transgenic models allowed the transmission of scrapie
isolates from either ARQ- or VRQ-bearing sheep (Vilotte
et al., 2001; Beringue et al., 2006; Baron & Biacabe, 2007).
The efficiency of transmission, however, was reported to be
highly variable depending on the isolate, with incubation
times ranging from less than 100 days for a VRQ/VRQ
isolate (Vilotte et al., 2001) up to 2 years for some ARQ/
ARQ isolates (Beringue et al., 2006).
Recently we have used the bank vole (Myodes glareolus,
formerly Clethrionomys glareolus) as a new and efficient
model for bioassay of TSEs from different species,
including man, sheep, goat, mouse and hamster (Cartoni
et al., 2005; Piening et al., 2006; Nonno et al., 2006; Agrimi
et al., 2008).
In this study, we report that voles are highly sensitive to
ARQ/ARQ and ARQ/VRQ scrapie isolates, one of which
has been shown to be refractory to transmission in classical
murine strains, thus allowing a relatively fast quantification
of infectivity in non-nervous tissues of scrapie-infected
sheep. Furthermore, we report the transmission of ARQ/
ARQ scrapie isolates from a flock of Suffolk sheep with
endemic scrapie, showing that voles are efficiently infected
by scrapie isolates which are poorly or not transmissible to
conventional and transgenic mouse models.
METHODS
Terminology. Throughout the manuscript we use ‘prion’ to refer to
the infectious agent of TSEs, ‘PrPSc’ to refer to the abnormal disease-
associated PrP isoform and ‘PrPres’ to refer to protease-resistant PrPSc
fragments.
Scrapie samples. In the present study five different scrapie sources
were inoculated in voles (Table 1). Of these, two (SSTB and SST7)
originated from the brain and the tonsils of the same sheep; two
(SCR6 and SCR1) were brain isolates from individual sheep whose
transmissions in mice have been previously reported (Bruce et al.,
2002); the last (SSUK6) was a brain pool.
SS7B and SS7T were obtained from an ARQ/ARQ Sarda sheep with
clinical scrapie reported in Italy in 1997.
SCR6 and SSUK6 were obtained from the same UK flock of Suffolk
sheep with endemic scrapie. SCR6 was from a clinically affected sheep
diagnosed in 1992, while SSUK6 originated from a pool of brains
collected in 2002 from 10 clinically affected sheep.
Finally, SCR1 was obtained from a scrapie-affected ARQ/VRQ
Grayface sheep collected in the UK in 1985.
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Transmission experiments. The inocula from SS7B, SS7T, SCR1
and SCR6 were prepared as 10% w/v homogenates (1021 dilution) in
PBS. For SS7B and SCR1, serial tenfold dilutions in PBS (1021 –
1026) were prepared and used for end-point titration into voles. For
the preparation of tonsil homogenate (SS7T), the tonsil was carefully
isolated free of surrounding tissues under a dissecting microscope.
The isolated tonsil was cut into small pieces and homogenized in a
Teflon–glass potter.
The brain pool SSUK6 was prepared as a 20% homogenate in 0.32 M
sucrose solution. Inocula for second passages were prepared as 10%
homogenates in PBS from the brain of individual voles culled at the
terminal stage of the disease.
The research protocol has been approved by the Service for
Biotechnology and Animal Welfare of the Istituto Superiore di
Sanita` and authorized by the Italian Ministry of Health, according to
Legislative Decree 116/92 (Decreto Legislativo, 1992), which has
implemented in Italy the European Directive 86/609/EEC (Council of
the European Communities, 1986) on laboratory animal protection.
Bank voles (Istituto Superiore di Sanita` breeding colony) and C57Bl/6
mice (Charles River, Como, Italy) were housed in standard cages and
treated according to Legislative Decree 116/92 guidelines, and animal
welfare was routinely checked by veterinarians from the Service for
Biotechnology and Animal Welfare. All animals were individually
identified by a passive integrated transponder.
Groups of 12–22 8-weeks-old voles and C57Bl/6 mice were injected
by the intracerebral (i.c.) route (20 ml) into the left cerebral
hemisphere under ketamine anaesthesia (0.1 mg ketamine g21).
Beginning 1 month after inoculation, animals were examined twice
per week until the appearance of neurological signs, and were then
examined daily. Diseased animals were culled with carbon dioxide at
the terminal stage of disease, but before neurological impairment
was such as to compromise welfare and, especially, adequate
drinking and feeding. Survival time was calculated as the interval
between inoculation and culling. Using the vole model, ID50 per
gram of SS7B and SCR1 was determined by end-point titration
according to the Spearman and Ka¨rber method (Hamilton et al.,
1977). Survivors were animals surviving to 900 days post-infection
(p.i.) (SS7B) or 700 days p.i. (SCR1) with no signs of infection
(confirmed by post-mortem analysis of brain by Western blot and
immunohistochemical detection). Animals culled for intercurrent
disease were analysed for brain PrPSc and excluded from analysis
when negative. The infectivity titre of SS7T was estimated by the
incubation time assay, using mean survival times derived from SS7B
end-point titration, best fitted to an exponential decay curve
(GraphPad Prism software).
Western Blot. SS7T and SS7B inocula (10% w/v homogenates in
PBS) were added with PBS/sarcosyl up to a final 2% sarcosyl (Sigma)
concentration. As a reference material (SBH) we prepared serial
twofold dilutions of a scrapie brain homogenate (10% w/v
homogenate in PBS with 2% sarcosyl from the medulla of an
ARQ/ARQ sheep with clinical scrapie) in 10% normal brain
homogenate. All samples were incubated for 20 min at room
temperature and then digested with proteinase K (200 mg ml21) for
1 h at 37 uC with gentle shaking. Protease treatment was stopped with
3 mM PMSF.
Brain homogenates (10% w/v) from individual voles were prepared
in 100 mM Tris/HCl, pH 7.4, containing 2% sarcosyl, incubated for
20 min at room temperature and then digested with proteinase K
(50 mg ml21) for 1 h at 37 uC with gentle shaking. Protease treatment
was stopped with 3 mM PMSF.
Electrophoresis and Western blotting were performed as described
previously (Nonno et al., 2006). Vole PrPres was detected with the
monoclonal antibody SAF84 (0.8 mg ml21; epitope at aa 163–173 of
the sheep PrP sequence), while the monoclonal antibody P4 (0.2 mg
ml21, epitope at aa 93–98) was used for sheep PrPres because of
its higher sensitivity, which was necessary to properly detect PrPres in
tonsil samples. Both antibodies were incubated for 1 h at room
temperature. The membranes were developed with an enhanced
chemiluminescence method (SuperSignal Femto, Pierce).
Chemiluminescence was detected with the VersaDoc imaging system
(Bio-Rad). Apparent molecular mass and glycoform patterns were
determined with QuantityOne software (Bio-Rad). For the analysis of
SS7B and SS7T PrPres content, chemiluminescence signals from the
SBH dilution series along with SS7B and SS7T were quantified with
QuantityOne software.
Histopathology, immunohistochemistry and paraffin-embed-
ded tissue (PET) blot. At post-mortem, each brain was divided into
two parts by a sagittal paramedian cut. The smaller portion was
immediately frozen and stored at 220 uC for Western blotting. The
remaining part was immersed and fixed in 10% formol saline for
4 days. The brains were trimmed at standard coronal levels,
decontaminated with formic acid for 1 h, and embedded in paraffin.
Sections (6 mm thick each) were cut for haematoxylin and eosin
staining, immunohistochemistry and PET blot, randomly mixed and
coded for blind pathological assessment.
For the construction of lesion profiles, vacuolar changes were scored
in nine grey-matter areas of the brain on haematoxylin and eosin-
stained sections, as described previously (Fraser & Dickinson, 1968;
Nonno et al., 2006). Vacuolation scores are derived from the
examination of at least six voles per group.
Table 1. Survival times of voles and C57Bl/6 mice infected with natural scrapie isolates
ND, Not determined.













Bank vole SS7B 14/14 14/14 14/14 188±33 100 10/10 102±6
SS7T 10/10 10/10 10/10 211±39 100 14/14 101±7
SCR6 18/18 18/18 18/18 197±19 100 11/11 98±4
SSUK6 22/22 22/22 22/22 175±18 100 11/11 96±4
SCR1 18/18 18/18 18/18 145±9 100 ND ND
C57Bl/6 mice SS7B 0/6 2/6 4/6 730±10 66 ND ND
SS7T 0/7 0/7 1/7 718 14 ND ND
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PET blot and PrP immunohistochemistry were performed as
described previously (Nonno et al., 2006).
For glial fibrillary acidic protein (GFAP) immunolabelling, depara-
ffinized sections were treated with 3% H2O2 in methanol for 10 min
at room temperature to abolish endogenous peroxidase activity and,
after heat-induced antigen retrieval (citrate buffer 0.01 M, pH 6.0,
165 min in microwave oven, 750 W), incubated 30 min with
polyclonal rabbit anti-cow GFAP (1 : 500, Dako-Cytomation).
Immunoreactivity was detected by the avidin–biotin-complex
(ABC) method as suggested by the suppliers.
In each immunohistochemistry run, positive and negative control
sections were included.
RESULTS
High sensitivity of voles to scrapie prions
All voles inoculated with 1021 dilution of an ARQ/ARQ
source of scrapie (SS7B) showed overt clinical signs and
succumbed to scrapie with a mean survival time of
188±33 days p.i. (mean±SD) (Table 1). Increasing
survival times were observed with 1022 and 1023 dilutions,
and dilutions greater than 1023 showed a decreasing attack
rate (Fig. 1a). The infectivity titre of SS7B was 105.5 i.c. ID50
U g21.
Transmission of a ARQ/VRQ sheep scrapie isolate (named
SCR1) to voles was rapid and efficient, with a survival time
of 145±9 days p.i. upon inoculation of 1021 dilution
(Table 1) and 100% attack rate up to 1023 dilution. The
SCR1 isolate contained 105.8 i.c. ID50 U g
21 (Fig. 1b).
Given the high sensitivity observed, we attempted the
transmission from the tonsil (SS7T) of the same ARQ/ARQ
scrapie-affected sheep (SS7B) used in titration experiments.
Following inoculation of SS7T, 100% of bank voles
developed clinical signs of disease, spongiform change
and PrPSc accumulation in the brain. The survival time was
211±39 days p.i. (Table 1). Clinical signs were similar in
voles inoculated either with the brain or the tonsil. The first
signs of disease were hyperactivity/reactivity followed by
the progressive disappearance of the typical hiding
behaviour. Overt neurological signs appeared later on,
consisting of characteristic head bobbing, accompanied by
severe and progressive ataxia of the forelimbs. The bobbing
movements of the head increased progressively and may
have resulted from visual difficulties. Hunched posture,
apathy and pronounced hypoactivity/reactivity preceded
sacrifice or death, which occurred 15–20 days after the
beginning of neurological signs.
C57Bl/6 mice were much less susceptible than voles to the
same inocula from ARQ/ARQ sheep (Table 1). They did
not show obvious clinical signs, although some animals
were culled after showing hyporeactivity, weight loss and
gait abnormalities. Since these signs were not specific and
often accompanied by the occurrence of age-related
diseases (tumours and skin lesions), it was impossible to
recognize evidence of scrapie on clinical grounds. However,
based on PrPSc accumulation and/or spongiform change,
four out of six and one out of seven animals, inoculated
with SS7B and SS7T, respectively, were identified as
positive after very long survival times (Table 1).
Brain and tonsil isolates show similar biological
properties, despite their discordant molecular
phenotype
It has been reported that PrPres isolated from lymphoid
tissues of sheep with scrapie displays electrophoretic
differences compared to brain PrPres (Madec et al., 2000).
We investigated the molecular properties of PrPres from
brain (SS7B) and tonsil (SS7T) isolates by Western






















































Fig. 1. End-point titration of scrapie infectivity in voles. Serial
dilutions of SS7B (a) and SCR1 (b) scrapie isolates were
inoculated i.c. in voles. Symbols represent individual survival times.
The diseased voles were positive for brain PrPres. Inoculated voles
that were not infected after 900 (a) or 700 days p.i. (b) are plotted
in compressed form after the x axes break point. Voles culled with
intercurrent disease are not included. The mean survival time
(days±SD) and the number of diseased/inoculated voles are
indicated on the right of each chart.
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et al., 2000), we observed that the electrophoretic profile
and the glycoform ratio of tonsil PrPres were distinct from
that of those found in brain (Fig. 2). The apparent
molecular mass of diglycosylated PrPres was indeed ~1 kDa
higher in tonsil, while monoglycosylated and unglycosy-
lated fragments were ~0.5 kDa lower. The glycotype was
characterized by the typical di .mono .unglycosylated
glycoform pattern in the brain, while in the tonsil mono-
glycosylated PrPres was the most abundant (Fig. 2b).
Similar findings were obtained with lymphoid tissues from
several sheep with natural or experimental scrapie (R.
Nonno, unpublished results).
In spite of these molecular differences, scrapie isolates from
brain and tonsil transmitted to voles with similar clinical
signs and survival times. Western blot analysis of PrPres
from the brain of voles of the two groups showed the same
molecular pattern (Fig. 3a), reminiscent of that observed in
the sheep brain isolate. Lesion profiles were also similar
(Fig. 3b).
In order to further compare their biological properties, we
thus set up subsequent transmission in voles. Upon second
passage, survival time in vole decreased to 102±6 days p.i.
for SS7B and 101±7 days p.i. for SS7T (Table 1). Western
blot analysis of PrPres from the brain of voles of the two
groups showed the same molecular profile (Fig. 3c), which
was also identical to that observed after primary passage
(compare Fig. 3a and c). Lesion profiles on second passages
showed some differences compared to primary passage
(compare Fig. 3b and d), suggestive of adaptation of these
isolates to voles (Kimberlin et al., 1987). Notwithstanding,
remarkably similar lesion profiles were obtained from voles
inoculated with the second passage of SS7B and SS7T
(Fig. 3d).
Relative infectivity titres in brain and tonsil
correlate with relative PrPSc levels
To quantify the relative amount of PrPres in SS7B an SS7T,
a dilution curve of a reference brain homogenate (SBH)
from the medulla oblongata of a sheep with clinical scrapie
was constructed. The amount of PrPres in 0.5 mg
equivalent of SS7B and SS7T, derived by plotting their
chemiluminescence signals on the linear regression of SBH
dilutions, was calculated as equivalent to the PrPres content
of 0.160 and 0.018 mg equivalent of SBH, respectively (Fig.
4). These results show that SS7T contains 8.8-fold less
PrPres than SS7B.
We then estimated the infectivity titre of tonsil (SS7T) by
the incubation time assay, based on the survival times
obtained in the end-point titration of the brain of the same
sheep (SS7B). The titre estimated in the tonsil homogenate
was 104.8 i.c. ID50 U g
21 (Fig. 5), i.e. fivefold lower
compared with that in the brain (SS7B). This estimate
correlates quite well with the relative levels of PrPres found
in tonsil and brain isolates.
Bank voles are susceptible to natural Suffolk
scrapie isolates
The natural Suffolk scrapie source investigated derives
from a single closed flock managed under near commercial
conditions and which has had endemic scrapie since 1990.
The flock has been intensively monitored over this period
and presents a consistent, uniform and distinctive
clinicopathological phenotype in ARQ/ARQ genotype
sheep (Hunter et al., 1997; Gonzalez et al., 2003),
suggesting that infection is maintained in the flock by a
single, stable sheep scrapie strain. Scrapie-affected sheep
from this flock thus represent a convenient source of
infected material for studying and quantifying the tissue
distribution of scrapie prions in sheep.
We investigated the susceptibility of voles to the above-
mentioned scrapie source by means of two different scrapie
isolates from the same flock: SCR6, an isolate collected in
1992 and already reported as being poorly transmissible to
mice (Bruce et al., 2002), and SSUK6, a brain pool
prepared in 2002.
All inocula gave 100% transmission rate in voles. Mean
survival times of voles inoculated with SCR6 and SSUK6
were 197±19 and 175±18 days p.i., respectively. Upon
second passage, survival times decreased to 95–100 days
p.i. with both isolates, similarly to what was previously
observed with SS7B and SS7T (Table 1). Voles developed
clinical disease with features indistinguishable from those
of SS7B and SS7T. We thus compared the pathological
phenotype induced by these ARQ/ARQ isolates in voles.
Upon second passages of SCR6, SSUK6, SS7B and SS7T,
PrPSc was abundant throughout the brain and showed a
similar distribution in all groups of voles. Prominent
immunolabelling was always observed in the frontal and
Fig. 2. Different PrPres profiling in brain and tonsil homogenates.
(a) Western blot analysis of PrPres from brain and tonsil
homogenates used for bioassay (SS7B and SS7T). PrPres was
detected with mAb P4. The positions of molecular mass markers
(kDa) are indicated. (b) Blot scans from the immunoblot in (a),
measured along the lanes of brain (black line) and tonsil (red line).
The chemiluminescence signals were normalized taking the
maximum value in each scan as 100%.
The bank vole as a sensitive bioassay for scrapie
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parietal cortices, septal nucleus, hippocampus, thalamus,
superior colliculi, geniculate nuclei, medulla oblongata,
vestibular nuclei and cerebellar cortex. In all voles,
distinctive features of PrPSc deposition were the accumula-
tion as focal deposits in all layers of the hippocampus, the
involvement of the stratum lacunosum moleculare and the
presence of focal PrPSc deposits in the molecular layer of
the dentate gyrus (Fig. 6a, b). In several individual brains,
prominent PrPSc aggregates were identified along the
alveus by immunohistochemistry and PET blot analysis
(Fig. 6a, b). Spongiform neurodegeneration was prominent
in all affected voles, accompanied by gliosis and neuronal
loss (Fig. 6c). There was evidence of diffuse astrocytosis,
revealed by GFAP immunohistochemical staining (Fig. 6d).
In several areas, including CA1 tract of the hippocampus,
there was a striking correlation between the severity of
vacuolation, gliosis, neuronal loss and the extent of PrPSc
deposition (Fig. 6). Lesion profiles of SCR6 and SSUK6
(Fig. 7) were remarkably similar to those obtained after
second passages of SS7B and SS7T (Fig. 3d).
DISCUSSION
Despite intensive studies on sheep scrapie, a number of
crucial questions remain unanswered, such as the natural
mode of transmission, the amount of infectivity which
accumulates in edible tissues at different stages of scrapie
infection and the extent of strain diversity in the field.
Studies using the mouse model for bioassay have proved to
be useful for recognizing scrapie strain diversity, but the
low sensitivity of mice to some scrapie sources and the
variable susceptibility to natural scrapie isolates limit
the utility of mouse bioassays. In this study, we report
that the bank vole represents a sensitive bioassay for the
detection and quantification of scrapie infectivity in sheep
tissues. The availability of an animal model which allows
fast and sensitive replication of scrapie prions will bring
new opportunities for the study of strains and for the
accurate measurement of infectivity.
Of note, several Italian scrapie isolates which transmitted
easily to voles, but not to mice (Piening et al., 2006),
including the ones used in the present study (SS7B and
SS7T), were previously reported to transmit quite ineffi-
ciently to tg338 transgenic mice harbouring the VRQ PrP
allele, being the group of isolates with the longest
incubation time in tg338 mice (Beringue et al., 2006).
Furthermore, the transmission of the same Suffolk scrapie
isolate used in the present study was also attempted to
tg338 mice, showing a similarly inefficient transmission (H.
Laude, Virologie et Immunologie Mole´culaires, INRA,
Jouy-en-Josas, France, personal communication). In con-
trast, our results show that voles allow a fast and efficient
replication of these ARQ/ARQ isolates, suggesting that this
new laboratory model can be useful for the study of a
Fig. 3. Similar molecular and pathological phenotypes in voles after primary and second passages of brain and tonsil isolates.
(a) and (c) Western blot analysis of PrPres from brain of individual voles after primary (a) or second (c) passage with SS7B and
SS7T. PrPres was detected with mAb SAF84. The molecular mass of markers is indicated. (b) and (d) Lesion profiles in voles
after primary (b) or second (d) passage with SS7B (closed circles) and SS7T (open circles). Brain-scoring positions are
medulla (1), cerebellum (2), superior colliculus (3), hypothalamus (4), thalamus (5), hippocampus (6), septum (7), retrosplenial
and adjacent motor cortex (8) and cingulate and adjacent motor cortex (9).
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scrapie strain harboured by both Italian and UK ARQ/ARQ
sheep. However, we cannot exclude that the advantage of
voles compared to other models might be limited to some
particular scrapie strains. Larger comparative studies are
required to investigate this issue.
Regarding the sensitivity of detection of low amounts of
sheep scrapie prions, limited data have been published to
date from transgenic mouse models expressing ovine PrP.
While the abrogation of the species barrier is expected to
endow ovine transgenic mouse models with an improved
sensitivity compared to wild-type mice, PrP overexpression
per se was reported to have no effect on limits of detection
(Fischer et al., 1996). Titration experiments performed in
transgenic mice expressing human or bovine PrP proved
that these models are useful for the detection of low
amounts of sporadic Creutzfeldt–Jakob (sCJD) and bovine
spongiform encephalopathy (BSE) prions, respectively
(Safar et al., 2002, 2005, Buschmann & Groschup, 2005).
The only titration experiment in an ovine transgenic mouse
model reported up to now shows that tg338 mice
expressing the sheep VRQ allele are able to measure 106.6
ID50 g
21 in a VRQ/VRQ scrapie isolate (Andre´oletti et al.,
2004). This is only five times higher than the titre measured
in the present study with the ARQ/VRQ SCR1 isolate (105.8
ID50 g
21). Although the biological variability of scrapie
isolates does not allow a direct comparison of titration
experiments performed with different isolates, the data
obtained with voles suggest that this model may
complement ovine transgenic models for bioassay of
scrapie prions, particularly for ARQ/ARQ scrapie isolates.
Based on the data obtained by end-point titration, we
expect that voles would be able to detect prions in tissues
which contain up to 3–4 orders of magnitude less
infectivity than the brain. In contrast, wild-type mice were
barely susceptible to undiluted brain homogenates. This
finding indicates that previous negative attempts to
quantify scrapie prions in edible tissues, such as muscles
and kidneys, or animal products, such as milk, may have
underestimated the infectivity titres. Recently, the use of
sensitive diagnostic methods has allowed the detection of
PrPSc in tissues such as skeletal muscles, kidneys, salivary
glands and mammary glands (Andre´oletti et al., 2004; Siso´
et al., 2006; Ligios et al., 2005, 2007; Vascellari et al., 2007),
and for which there was no previous evidence of scrapie
infectivity (Detwiler & Baylis, 2003). Interestingly, PrPres
quantification in these tissues was reported to be 2–4 log
lower than in the brain, suggesting that bioassay in vole
should be able to quantify their infectivity. The quantifica-
tion of infectivity present in such tissues from sheep with
pre-clinical and clinical scrapie is of crucial importance for
public health reasons, as it will conceivably allow a more
appropriate assessment of the risk posed by these products,
and for gaining insight into scrapie pathogenesis and the
natural mode of sheep-to-sheep transmission.
The quantification of infectivity by end-point titration is
time-consuming and requires the use of large numbers of
animals, and thus animal models with enhanced sensitivity
can also be limited in their use by both practical and ethical
issues. In the present study, we investigated the use of
Fig. 4. Quantification of PrPres in the tonsil homogenate used for
bioassay. (a) Western blot analysis of PrPres from brain and tonsil
homogenates (0.5 mg equivalent/lane) along with twofold dilutions
of a reference brain homogenate (SBH). PrPres was detected with
mAb P4. (b) Linear regression of chemiluminescence signal
measured from the dilution curve of SBH (open squares).
Interpolated x values for SS7B (open circle) and SS7T (closed
circle) were 0.16 and 0.018 mg equivalent of SBH, respectively.
Fig. 5. Determination of prion titre in tonsil by incubation time
assay. Non-linear regression analysis prion titre against mean
survival time (±SEM) of voles inoculated with serial dilutions of
SS7B (closed circles). Interpolated y value for SS7T (open circle)
was 104.8 i.c. ID50 U g
”1.
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possible alternatives by estimating the levels of infectivity
present in the tonsil from a scrapie affected sheep either by
incubation time assay, or by PrPres quantification.
Incubation time assay was developed several years ago,
based on the finding that time intervals between inocu-
lation and onset of illness were inversely proportional to
the size of the dose injected by the intracerebral route
(Prusiner et al., 1982). It is known, however, that different
prion strains can have variable incubation times in the
same host, and the relationship between the size of the dose
and incubation time is valid only when comparing inocula
containing the same prion strain. Thus, an important
prerequisite for the use of incubation time assay to estimate
infectious titres in different tissues is that all tissues
harbour the same strain. It has been suggested that strains
are encoded in the conformation of PrPSc aggregates
(Telling et al., 1996) and this, at least in part, can be
deduced by the electrophoretic profile of PrPres (Bessen &
Marsh, 1994). It was previously reported that PrPres
extracted from lymphoid tissues of sheep with scrapie
(Madec et al., 2000) and of human patients with vCJD
(Wadsworth et al., 2001) has molecular features different
from brain PrPres, and these differences can be interpreted
as suggestive of the presence of different prion strains in
nervous and lymphoreticular tissues. We analysed PrPres in
tonsil from a scrapie-affected sheep by Western blot,
showing that the molecular mass and the glycoform ratio is
indeed different from brain PrPres, and these findings have
been confirmed in several sheep with natural or experi-
mental scrapie (R. Nonno, unpublished results). These
results prompted us to compare in voles the biological
properties of scrapie prions from brain and tonsil. They
showed similar incubation time upon second passage and
indistinguishable brain regional distribution of vacuolation
upon first and second passages. Furthermore, we found
that voles infected with tonsil and brain homogenates
accumulate PrPres with identical electrophoretic profile.
Overall, these results suggest that brain and tonsil
harboured the same prion strain showing different
glycoprofiles in relation to the different cellular/tissue
Fig. 6. Immunohistochemical and histological analysis of hippocampus from voles infected with vole-passaged scrapie isolate
SSUK6. Serial sections of the hippocampus were analysed by immunohistochemistry for PrP (a), PET blot (b), haematoxylin and








Scoring area in brain













Fig. 7. Similar pathological phenotypes in voles after second
passage of SCR6 and SSUK6 isolates. Lesion profiles in voles
infected with SCR6 (closed circles) and SSUK6 (closed square).
Brain-scoring positions are as in Fig. 3.
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types in which it replicated, and that incubation time assay
can be exploited for estimating the infectious titres in
lymphoreticular tissues of sheep with scrapie. The infec-
tious titre estimated for the tonsil homogenate was ~ 1 log
less than that found in brain, which is consistent with
previous findings (Hadlow et al., 1982), indicating that
lymphoreticular tissues can contain very high levels of
infectivity.
Importantly, we were able to quantify the level of PrPres in
the tonsil relative to the brain and found that the relative
amounts of PrPres and infectivity were consistent. This
consistency is very promising as it shows that the
relationship between brain and tonsil is similar when
measured either by PrPres or by intracerebral vole ID50 and
indicates that in principle, although endowed with tissue-
specific modifications, PrPres can be exploited as a useful
marker for the quantification of scrapie infectivity.
In order to validate the use of PrPres as a quantitative
marker of infectivity, it is necessary to perform more
detailed studies comparing PrPres and infectivity in
different tissues, such as kidneys, salivary glands and
muscles. Natural sheep scrapie represents an appropriate
model for acquiring knowledge on the relationships
between PrPSc and infectivity, which may also be extrap-
olated to other TSEs. The natural Suffolk scrapie source
investigated derives from a closed flock maintained since
1980 in which the first case of scrapie occurred in 1990.
Thereafter an increase in incidence of scrapie was observed.
This flock was subsequently bred to ensure the mainten-
ance of susceptible genotypes and managed to allow the
perpetuation of infection. Scrapie isolates from this source
do not transmit efficiently to wild-type mice (Bruce et al.,
2002) and transmit with long incubation times to tg338
mice (H. Laude, personal communication). In search for
an ideal source of sheep with natural scrapie, we
investigated the susceptibility of voles to scrapie isolates
from this Suffolk flock. The two scrapie isolates studied
transmitted very efficiently to voles and induced incuba-
tion times and lesion profiles very similar to those observed
with Italian ARQ/ARQ scrapie isolates, suggesting that UK
and Italian ARQ/ARQ isolates may harbour the same
scrapie strain. Furthermore, transmission in tg338 mice of
the same isolates studied here also shows that they have
similar biological properties (Beringue et al., 2006; H.
Laude, personal communication). These findings suggest
that voles are a promising animal model for bioassay of
non-nervous tissues of Suffolk sheep infected with scrapie
and prompt us to exploit this model with the objective to
validate PrPres as a quantitative marker for scrapie
infectivity.
In summary, we report on the sensitivity of bank voles to
sheep scrapie, showing that this animal model allows the
sensitive detection of prions from two unrelated scrapie
sources, one of which is refractory to isolation in
conventional mouse models and in at least one over-
expressing transgenic line. Furthermore, we investigated
the relationships between PrPSc molecular characteristics,
strain and infectious titre in the brain and tonsil of the
same scrapie-affected sheep, showing that a PrPSc-based
estimate of scrapie infectivity in sheep tissues could in
principle be achieved by combining sensitive PrPres
detection methods and bioassay in voles.
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